Martin Burian

4.5k total citations
38 papers, 832 citations indexed

About

Martin Burian is a scholar working on Surgery, Oncology and Otorhinolaryngology. According to data from OpenAlex, Martin Burian has authored 38 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Oncology and 11 papers in Otorhinolaryngology. Recurrent topics in Martin Burian's work include Head and Neck Cancer Studies (11 papers), Angiogenesis and VEGF in Cancer (7 papers) and Salivary Gland Tumors Diagnosis and Treatment (6 papers). Martin Burian is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Angiogenesis and VEGF in Cancer (7 papers) and Salivary Gland Tumors Diagnosis and Treatment (6 papers). Martin Burian collaborates with scholars based in Austria, Germany and France. Martin Burian's co-authors include Csilla Neuchrist, Boban M. Erović, Claudia Gedlicka, Michael Formanek, Alessandra Handisurya, Georg Steiner, Antonius C. Kierner, Heinz Regele, J. Kornfehl and Michael B. Fischer and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Martin Burian

36 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Burian Austria 15 252 250 221 201 140 38 832
Volker Hans Schartinger Austria 17 223 0.9× 294 1.2× 150 0.7× 199 1.0× 214 1.5× 45 847
Yong Kil Hong South Korea 16 277 1.1× 92 0.4× 239 1.1× 127 0.6× 119 0.8× 40 858
Shin Ito Japan 14 167 0.7× 127 0.5× 96 0.4× 107 0.5× 57 0.4× 61 599
Samuli Vaittinen Finland 13 402 1.6× 179 0.7× 346 1.6× 57 0.3× 40 0.3× 22 1.1k
Martin Chovanec Czechia 20 361 1.4× 353 1.4× 253 1.1× 105 0.5× 110 0.8× 95 1.2k
Gillian L. Hall United Kingdom 18 304 1.2× 282 1.1× 245 1.1× 102 0.5× 378 2.7× 32 1.0k
Akihiko Oyama Japan 16 126 0.5× 287 1.1× 435 2.0× 75 0.4× 40 0.3× 76 941
Ronghui Xia China 15 399 1.6× 320 1.3× 246 1.1× 88 0.4× 114 0.8× 55 848
Matei A. Banu United States 22 379 1.5× 111 0.4× 471 2.1× 78 0.4× 58 0.4× 50 1.2k
Ying Guo China 16 153 0.6× 172 0.7× 221 1.0× 90 0.4× 20 0.1× 58 814

Countries citing papers authored by Martin Burian

Since Specialization
Citations

This map shows the geographic impact of Martin Burian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Burian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Burian more than expected).

Fields of papers citing papers by Martin Burian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Burian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Burian. The network helps show where Martin Burian may publish in the future.

Co-authorship network of co-authors of Martin Burian

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Burian. A scholar is included among the top collaborators of Martin Burian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Burian. Martin Burian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tourneau, Christophe Le, Zoltán Takácsi‐Nagy, Sandra Nuyts, et al.. (2025). Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC. Future Oncology. 21(12). 1489–1499. 3 indexed citations
2.
3.
Fuereder, Thorsten, Konrad Klinghammer, Birgit Grünberger, et al.. (2024). 880P Paclitaxel plus cetuximab for the treatment of recurrent and/or metastatic head and neck cancer after first-line checkpoint inhibitor failure: Primary analysis from the pace ace trial. Annals of Oncology. 35. S629–S629. 2 indexed citations
4.
5.
Panhofer, Peter, Martin Burian, Sebastian F. Schoppmann, et al.. (2012). Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction. Langenbeck s Archives of Surgery. 398(2). 221–230. 9 indexed citations
6.
Keil, Felix, Edgar Selzer, Andrea Berghold, et al.. (2012). Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck. European Journal of Cancer. 49(2). 352–359. 21 indexed citations
7.
Kornek, Gabriela, Barbara Bachtiary, Edgar Selzer, et al.. (2011). Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced. Wiener klinische Wochenschrift. 123(7-8). 215–221. 24 indexed citations
8.
Bigenzahn, Wolfgang, Martin Burian, J. Kornfehl, et al.. (2006). Superimposed high-frequency jet ventilation (SHFJV) for endoscopic laryngotracheal surgery in more than 1500 patients. British Journal of Anaesthesia. 96(5). 650–659. 57 indexed citations
9.
Neuchrist, Csilla, Boban M. Erović, Alessandra Handisurya, et al.. (2003). Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head & Neck. 25(6). 464–474. 99 indexed citations
10.
Gedlicka, Claudia, B. Schüll, Michael Formanek, et al.. (2002). Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies. Anti-Cancer Drugs. 13(5). 491–495. 14 indexed citations
11.
Gedlicka, Claudia, Michael Formanek, Edgar Selzer, et al.. (2002). Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck. Oncology. 63(2). 145–150. 34 indexed citations
12.
Muhm, Manfred, et al.. (2002). Carotid Resection and Reconstruction for Locally Advanced Head and Neck Tumors. Acta Oto-Laryngologica. 122(5). 561–564. 13 indexed citations
13.
Neuchrist, Csilla, Boban M. Erović, Alessandra Handisurya, et al.. (2001). Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck. The Laryngoscope. 111(10). 1834–1841. 53 indexed citations
14.
Kierner, Antonius C., et al.. (2001). How Do the Cervical Plexus and the Spinal Accessory Nerve Contribute to the Innervation of the Trapezius Muscle?. Archives of Otolaryngology - Head and Neck Surgery. 127(10). 1230–1230. 51 indexed citations
15.
Thurnher, Dietmar, J. Kornfehl, Martin Burian, et al.. (2001). Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck. Anti-Cancer Drugs. 12(3). 205–208. 5 indexed citations
16.
Burian, Martin, et al.. (2000). Lokal fortgeschrittene Tumoren des HNO-Traktes: Moderne Therapiekonzepte. Oncology Research and Treatment. 23(2). 177–182. 1 indexed citations
17.
Burian, Martin. (1999). Angiogenic Factors in Laryngeal Carcinomas: Do They Have Prognostic Relevance?. Acta Oto-Laryngologica. 119(2). 289–292. 42 indexed citations
18.
Neuchrist, Csilla, et al.. (1999). Expression of Basic Fibroblast Growth Factor in Squamous Cell Carcinomas of the Larynx – Examination by in situ Hybridization. Oncology Research and Treatment. 22(1). 41–46. 2 indexed citations
19.
Pammer, Johannes, Wolfgang Weninger, Michael Mildner, et al.. (1998). Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. The Journal of Pathology. 186(2). 186–191. 52 indexed citations
20.
Matula, Christian, et al.. (1997). Primary Neuroendocrine (Merkel Cell) Carcinoma of the Anterior Skull Base. Skull base. 7(3). 151–158. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Volker Hans Schartinger Breakdown of academic impact, for papers by Yong Kil Hong Breakdown of academic impact, for papers by Shin Ito Breakdown of academic impact, for papers by Samuli Vaittinen Breakdown of academic impact, for papers by Martin Chovanec Breakdown of academic impact, for papers by Gillian L. Hall Breakdown of academic impact, for papers by Akihiko Oyama Breakdown of academic impact, for papers by Ronghui Xia Breakdown of academic impact, for papers by Matei A. Banu Breakdown of academic impact, for papers by Ying Guo
Rankless by CCL
2026